Journal
NEURO-ONCOLOGY
Volume 17, Issue 1, Pages 53-62Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/neuonc/nou139
Keywords
glioma animal model; invasion; nitroxoline; PTEN; 8-hydroxy-5-nitroquinoline
Categories
Funding
- Clinical and Translational Science Institute (CTSI) at the David Geffen School of Medicine at UCLA
Ask authors/readers for more resources
Background. Nitroxoline is an FDA-approved antibiotic with potential antitumor activity. Here we evaluated whether nitroxoline has antiproliferative properties on glioma cell growth in vitro and in vivo using glioma cell lines and a genetically engineered PTEN/KRAS mouse glioma model. Methods. The effect of nitroxoline treatment on U87 and/or U251 glioma cell proliferation, cell-cycle arrest, invasion, and ability to induce an apoptotic cascade was determined in vitro. Magnetic resonance imaging was used to measure glioma volumes in genetically engineered PTEN/KRAS mice prior to and after nitroxoline therapy. Induction of apoptosis by nitroxoline was evaluated at the end of treatment using terminal deoxyribonucleotidyl transferase (TDT)-mediated dUTP-digoxigenin nick end labeling (TUNEL). Results. Nitroxoline inhibited the proliferation and invasion of glioblastoma cells in a time-and dose-dependent manner in vitro. Growth inhibition was associated with cell-cycle arrest in G(1)/G(0) phase and induction of apoptosis via caspase 3 and cleaved poly(-ADP-ribose) polymerase. In vivo, nitroxoline-treated mice had no increase in tumor volume after 14 days of treatment, whereas tumor volumes doubled in control mice. Histological examination revealed 15%-20% TUNEL-positive cells in nitroxoline-treated mice, compared with similar to 5% in the control group. Conclusion. Nitroxoline induces apoptosis and inhibits glioma growth in vivo and in vitro. As an already FDA-approved treatment for urinary tract infections with a known safety profile, nitroxoline could move quickly into clinical trials pending confirmatory studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available